[HTML][HTML] Thrombolysis with intravenous tissue plasminogen activator predicts a favorable discharge disposition in patients with acute ischemic stroke
NL Ifejika-Jones, N Harun, NA Mohammed-Rajput… - Stroke, 2011 - journals.lww.com
Background and Purpose—Acute ischemic stroke patients who receive recombinant tissue
plasminogen activator (rt-PA) within 3 hours of symptom onset are 30% more likely to have
minimal to no disability at 3 months. During hospitalization, short-term disability is
subjectively measured by discharge disposition, whether to home, inpatient rehabilitation, a
skilled nursing facility, or subacute care. There are no studies assessing the role of
recombinant tissue plasminogen activator use as a predictor of poststroke discharge …
plasminogen activator (rt-PA) within 3 hours of symptom onset are 30% more likely to have
minimal to no disability at 3 months. During hospitalization, short-term disability is
subjectively measured by discharge disposition, whether to home, inpatient rehabilitation, a
skilled nursing facility, or subacute care. There are no studies assessing the role of
recombinant tissue plasminogen activator use as a predictor of poststroke discharge …
以上显示的是最相近的搜索结果。 查看全部搜索结果